Head and Neck Carcinoma of Unknown Primary
7 clinical trials · Condition
◉ Watch Head and Neck Carcinoma of Unknown Primary
| Record | Firm | Date |
|---|---|---|
| Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer (NCT04754321) | Ohio State University Comprehensive Cancer Center | 2022-05-12 |
| Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer (NCT05245682) | Emory University | 2022-02-17 |
| Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study (NCT05075980) | Mayo Clinic | 2022-02-16 |
| Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries (NCT04489212) | Mayo Clinic | 2020-10-06 |
| Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer (NCT02567422) | National Cancer Institute (NCI) | 2017-04-17 |
Track Head and Neck Carcinoma of Unknown Primary automatically
Every clearance here is in the API, with alerts when new ones post.